PK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma

Clinical trial NCT03488251 · TERMINATED

Trial details

NCT number

NCT03488251

Sponsor

Molecular Templates, Inc.

Status

TERMINATED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2018-08-20

Primary completion

2021-03-12

Enrollment

8

View on ClinicalTrials.gov